Immunological Evaluation of Individuals Infected with Acinetobacter baumannii

Document Type : Original Articles

Authors

1 Department of Dentist, Al-Rafidain University College, Baghdad, Iraq

2 Biology Department, College of Science, Mustansiriyah University, Baghdad, Iraq

Abstract

Acinetobacter baumannii (A. baumannii) is a spherical rod-shaped Gram-negative non-lactose fermenting (Coccobacilli, Aerobic bacteria) bacteria. It is a member of the Moraxellacea family. A. baumannii is a pathogenic, opportunistic organism that infects humans in society and hospitals. In particular, patients with immune system defects are at risk, especially those with burn infections and those hospitalized in intensive care (ICU). It plays a vital role in many illnesses, including septicemia, pneumonia, meningitis, soft tissues, skin infection, endocarditis, and urinary tract infection (UTI). The current study included immunological evaluation of infection with A. baumannii. In the current study, 150 blood samples were obtained as follows: 100 blood samples were collected from infected individuals with A. baumannii admitted to hospitals in Baghdad. Fifty blood samples were obtained from healthy individuals and considered as the control. 10 ml of blood samples were collected from the venous blood of the participants. A. baumannii was collected and isolated from infected patients and diagnosed by traditional methods, using different culture media (MacConkey agar, blood agar, and Chromogenetic agar) and by biochemical assays, then the bacteria diagnosis was confirmed using the VITEK 2 ID-GN cards. Microscopic examination and culture diagnosis of bacteria were conducted, and the diagnosis was confirmed by complete biochemical examinations using VITEK2 Compact System. Assessments included the serum level of IL-17A and TNF-α for hospitalized patients infected with A. baumannii. The study recorded a significant increase in the serum level of IL-17A for patients infected with A. baumannii (479.83±26.21 pg/ml) compared to control subjects (69.32±4.53 pg/ml). The recorded data showed a significant increase in the serum level of TNF-α for patients infected with A. baumannii (98.05±28.89 pg/ml) compared to control (1.40±25.12 pg/ml).

Keywords

Main Subjects

References

  1. Asif M, Alvi IA, Rehman SU. Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities. Infect Drug Re. 2018;11:1249.
  2. Chapartegui-González I, Lázaro-Díez M, Bravo Z, Navas J, Icardo JM, Ramos-Vivas J. Acinetobacter baumannii maintains its virulence after long-time starvation. PloS One. 2018;13(8):0201961.
  3. Tille P. Bailey & Scott's diagnostic microbiology-E-Book: Elsevier Health Sciences; 2015.
  4. Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J Biol Sci. 2018;25(3):586-96.
  5. Li L-H, Yang Y-S, Sun J-R, Huang T-W, Huang W-C, Chen F-J, et al. Clinical and molecular characterization of Acinetobacter seifertii in Taiwan. J Antimicrob Chemoth. 2021;76(2):312-21.
  6. KhalaweTektook N. Study the virulence factors and patterns of antibiotics resistance in acinetobacter baumannii isolated from hospitalized patients in Baghdad City. Pak J Biotechnol. 2018;15(1):19-23.
  7. Gallego L. Acinetobacter baumannii: Factors involved in its high adaptability to adverse environmental conditions. J Microbiol Exp. 2016;3(2):00085.
  8. Uppalapati SR, Sett A, Pathania R. The outer membrane proteins OmpA, CarO, and OprD of Acinetobacter baumannii confer a two-pronged defense in facilitating its success as a potent human pathogen. Front Microbiol. 2020:2441.
  9. Payam MA, Rasooli I, Owlia P, Talei D, Alipour SD. Correlation of virulence factors and cell sdhesion of clinical isolates of Acinetobacter baumannii. Arch Clin Infect Dis. 2018;13(3):62841.
  10. Cillóniz C, Dominedò C, Torres A. Multidrug resistant gram-negative bacteria in community-acquired pneumonia. Annual Update in Intensive Care and Emergency Medicine 2019. 2019:459-75.
  11. Yan Z, Yang J, Hu R, Hu X, Chen K. Acinetobacter baumannii infection and IL-17 mediated immunity. Mediators Inflamm. 2016;2016.
  12. Morris FC, Dexter C, Kostoulias X, Uddin MI, Peleg AY. The mechanisms of disease caused by Acinetobacter baumannii. Front Microbiol. 2019;10:1601.
  13. Sato Y, Unno Y, Miyazaki C, Ubagai T, Ono Y. Multidrug-resistant Acinetobacter baumannii resists reactive oxygen species and survives in macrophages. Sci Rep. 2019;9(1):1-12.
  14. Parameswaran N, Patial S. Tumor necrosis factor-α signaling in macrophages. Crit Rev Eukaryot Gene Expr. 2010;20(2).
  15. Webster JD, Vucic D. The balance of TNF mediated pathways regulates inflammatory cell death signaling in healthy and diseased tissues. Front Cell Dev Biol. 2020;8:365.
  16. Bullock NO, Aslanzadeh J. Biochemical profile-based microbial identification systems. Advanced techniques in diagnostic microbiology: Springer; 2013. p. 87-121.
  17. Abramson JH. WINPEPI updated: computer programs for epidemiologists, and their teaching potential. Epidemiol Perspect Innov. 2011;8(1):1-9.
  18. Bagudo AI, Obande GA, Harun A, Singh KKB. Advances in automated techniques to identify complex. Asian Biomed.14(5):177-86.
  19. Ganda RP, Soehita S. Suitability Tests for Bacterial Identification and Antibiotic Sensitivity Tests using Microscan Walkaway on Vitek 2. Indian J Forensic Med Toxicol. 2021;15(2).
  20. Eisenreich W, Rudel T, Heesemann J, Goebel W. How viral and intracellular bacterial pathogens reprogram the metabolism of host cells to allow their intracellular replication. Front Cell Infect Microbiol. 2019;9:42.
  21. Tiku V, Tan M-W. Host immunity and cellular responses to bacterial outer membrane vesicles. Trends Immunol. 2021;42(11):1024-36.
  22. Chen W. Host innate immune responses to Acinetobacter baumannii infection. Front Cell Infect Microbiol. 2020:486.
  23. García-Patiño MG, García-Contreras R, Licona-Limón P. The immune response against Acinetobacter baumannii, an emerging pathogen in nosocomial infections. Front Immunol. 2017;8:441.
  1. Cheng J, Yan J, Reyna Z, Slarve M, Lu P, Spellberg B, et al. Synergistic rifabutin and colistin reduce emergence of resistance when treating Acinetobacter baumannii. Antimicrob Agents Chemother. 2021;65(4):e02204-20.
  2. Kim C, Ndegwa E. Influence of pH and temperature on growth characteristics of leading foodborne pathogens in a laboratory medium and select food beverages. 2018.
  3. Metzemaekers M, Gouwy M, Proost P. Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol. 2020;17(5):433-50.
  4. Kikuchi-Ueda T, Ubagai T, Kamoshida G, Nakano R, Nakano A, Ono Y. Acinetobacter baumannii LOS Regulate the Expression of Inflammatory Cytokine Genes and Proteins in Human Mast Cells. Pathogens. 2021;10(3):290.
Archives of Razi Institute
Volume 77, Issue 5 - Serial Number 5
September and October 2022
Pages 1813-1819

Files

Share

How to cite

Statistics